We are for the first time able to provide enterprise-wide seamless integration of actionable pharmacogenetics (PGx) data from the Pharmacoscan(TM) pharmacogenetics test platform used in our clinical laboratory with medication decision support for all of our physicians.
MIAMI (PRWEB) January 11, 2023
Nicklaus Children’s Hospital, South Florida’s only licensed specialty hospital exclusively for children, is taking a major step forward in personalizing patient care using genetics by using the ActX Genomic Decision Support platform. The ActX service is connected into the Oracle Cerner Electronic Health Record to provide physicians with real-time alerts based on the patient’s genetics, all within normal physician workflow.
After genetic testing, the results are uploaded into the ActX platform, and immediately become actionable within Oracle Cerner Millennium. For example, when a physician goes to prescribe a medication, an automatic background check against the patient’s genetics occurs, and the physician is alerted if drug efficacy, risk of side effects, or dosing are affected by the patient’s genetics. A genomic profile for each patient is also now part of the patient chart.
“Our partnership with ActX is a cornerstone for clinical precision medicine at Nicklaus Children’s Hospital” said Steven J. Melnick, Ph.D., M.D. Chief, Department of Pathology and Clinical Laboratories Medical Director, Nicklaus Children’s Biobank.
“We are for the first time able to provide enterprise-wide seamless integration of actionable pharmacogenetics (PGx) data from the Pharmacoscan(TM) pharmacogenetics test platform used in our clinical laboratory with medication decision support for all of our physicians. We are confident that this functionality will vastly improve safety and efficacy of medical therapy for our patients. Beyond PGx, we look forward to continuing our partnership with ActX with expansion of other areas of genomic data integration in the years to come.”
In addition to pharmacogenomics, Nicklaus plans to expand the platform use across many other genetic conditions.
“We are excited to partner with Nicklaus Children’s Hospital as they bring precision medicine to patient care at the bedside or in the clinic. With ActX Genomic Decision Support connected directly into their Cerner (Millennium) EHR, ActX will provide seamless point of care decision support to Nicklaus’s physicians. Our shared goal is to help improve patient outcomes” said Andrew Ury, MD and CEO of ActX.
About Nicklaus Children’s Hospital
Founded in 1950 by Variety Clubs International, Nicklaus Children’s Hospital is South Florida’s only licensed specialty hospital exclusively for children, with approximately 800 attending physicians, including more than 500 pediatric subspecialists. The 309-bed hospital, known as Miami Children’s Hospital from 1983 through 2014, is renowned for excellence in all aspects of pediatric medicine with many specialty programs routinely ranked among the best in the nation by U.S. News & World Report since 2008. The hospital is also home to the largest pediatric teaching program in the southeastern United States and since 2003 has been designated an American Nurses Credentialing Center (ANCC) Magnet facility, the nursing profession’s most prestigious institutional honor.
The Nicklaus Children's Hospital network includes more than a dozen outpatient centers extending from Martin County to southern Miami-Dade County, offering a range of pediatric healthcare services, including urgent care, rehabilitation services and subspecialty physician appointments for children of all ages, including up to age 21.
Nicklaus Children’s Hospital is committed to being a resource for children from throughout South Florida and around the world.
ActX is the industry leader in EHR-integrated precision medicine. Our service helps physicians make better decisions about medical treatment, using a patient’s genetic information to guide therapy. The ActX Genomic Service offers proven, tightly integrated, real-time genomic decision support for medication orders and actionable genomic risks, a built-in patient Genomic Profile, and the ability to fully customize content.
As medications are ordered, and before the prescription is finalized, medications are checked against the patient’s genetics for efficacy, adverse reactions, and dosing. Extensive evidence based and actionable content is provided as default, customizable content, covering hundreds of genes. You can easily suppress any content or interactions, or add or modify content.
For more information, visit http://www.actx.com, email email@example.com or call 888-998-2289.